nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbetocin—OXTR—prostate gland—prostate cancer	0.0984	0.595	CbGeAlD
Carbetocin—OXTR—renal system—prostate cancer	0.0671	0.405	CbGeAlD
Carbetocin—OXTR—Peptide GPCRs—MC2R—prostate cancer	0.0248	0.0297	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—RGS17—prostate cancer	0.0213	0.0255	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—RLN2—prostate cancer	0.0161	0.0193	CbGpPWpGaD
Carbetocin—OXTR—G alpha (q) signalling events—GRPR—prostate cancer	0.0144	0.0172	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—GRPR—prostate cancer	0.0142	0.017	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—GRPR—prostate cancer	0.0129	0.0154	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—MC2R—prostate cancer	0.0117	0.014	CbGpPWpGaD
Carbetocin—OXTR—GPCRs, Class A Rhodopsin-like—GRPR—prostate cancer	0.0111	0.0133	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—RLN2—prostate cancer	0.0108	0.013	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—GSTO1—prostate cancer	0.0104	0.0125	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—PENK—prostate cancer	0.0104	0.0125	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—LPAR1—prostate cancer	0.0101	0.0121	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—GRPR—prostate cancer	0.00953	0.0114	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—PDE4D—prostate cancer	0.00951	0.0114	CbGpPWpGaD
Carbetocin—OXTR—GPCRs, Class A Rhodopsin-like—MC2R—prostate cancer	0.00913	0.0109	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—GNG5—prostate cancer	0.00905	0.0108	CbGpPWpGaD
Carbetocin—OXTR—G alpha (q) signalling events—GNRH1—prostate cancer	0.00895	0.0107	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—ATF3—prostate cancer	0.00878	0.0105	CbGpPWpGaD
Carbetocin—OXTR—G alpha (q) signalling events—GRP—prostate cancer	0.00867	0.0104	CbGpPWpGaD
Carbetocin—OXTR—G alpha (q) signalling events—LPAR1—prostate cancer	0.00867	0.0104	CbGpPWpGaD
Carbetocin—OXTR—G alpha (q) signalling events—PLCB2—prostate cancer	0.00858	0.0103	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—GRP—prostate cancer	0.00856	0.0103	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—CX3CL1—prostate cancer	0.00831	0.00996	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—IGFBP3—prostate cancer	0.00826	0.0099	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—RLN2—prostate cancer	0.00824	0.00987	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—prostate cancer	0.00801	0.00959	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—MC2R—prostate cancer	0.00782	0.00937	CbGpPWpGaD
Carbetocin—OXTR—G alpha (q) signalling events—GNG5—prostate cancer	0.00779	0.00933	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—LPAR1—prostate cancer	0.00775	0.00929	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—prostate cancer	0.00775	0.00929	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—PRKACB—prostate cancer	0.00771	0.00924	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB2—prostate cancer	0.00768	0.0092	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—PRKCZ—prostate cancer	0.00728	0.00872	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—GRPR—prostate cancer	0.00725	0.00869	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—PENK—prostate cancer	0.00697	0.00835	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—GNG5—prostate cancer	0.00697	0.00835	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—CALCA—prostate cancer	0.00694	0.00832	CbGpPWpGaD
Carbetocin—OXTR—G alpha (q) signalling events—ANXA1—prostate cancer	0.00638	0.00764	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—ANXA1—prostate cancer	0.0063	0.00755	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—WNT4—prostate cancer	0.00624	0.00748	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—PRKCQ—prostate cancer	0.00619	0.00741	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—OR51E2—prostate cancer	0.00614	0.00736	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—MC2R—prostate cancer	0.00596	0.00714	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—GNRH1—prostate cancer	0.00593	0.0071	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—GJA1—prostate cancer	0.00593	0.0071	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—CXCL12—prostate cancer	0.00576	0.0069	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—LPAR1—prostate cancer	0.00574	0.00688	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—GRP—prostate cancer	0.00574	0.00688	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—prostate cancer	0.00571	0.00684	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—OR51E2—prostate cancer	0.00558	0.00669	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—CX3CL1—prostate cancer	0.00557	0.00668	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—ITPR1—prostate cancer	0.0055	0.00659	CbGpPWpGaD
Carbetocin—OXTR—G alpha (q) signalling events—PRKCQ—prostate cancer	0.00532	0.00638	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—PENK—prostate cancer	0.00531	0.00636	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—RGS17—prostate cancer	0.00522	0.00626	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—PRKCQ—prostate cancer	0.00476	0.00571	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—RGS17—prostate cancer	0.00474	0.00568	CbGpPWpGaD
Carbetocin—OXTR—G alpha (q) signalling events—ITPR1—prostate cancer	0.00473	0.00567	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—RLN2—prostate cancer	0.00466	0.00558	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—GNRH1—prostate cancer	0.00451	0.00541	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—LPAR1—prostate cancer	0.00437	0.00524	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—GRP—prostate cancer	0.00437	0.00524	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—PLXNB1—prostate cancer	0.00426	0.0051	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—CX3CL1—prostate cancer	0.00424	0.00509	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—prostate cancer	0.00423	0.00507	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—RLN2—prostate cancer	0.00423	0.00507	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—ANXA1—prostate cancer	0.00422	0.00506	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—GRPR—prostate cancer	0.0041	0.00491	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—GNG5—prostate cancer	0.00393	0.00471	CbGpPWpGaD
Carbetocin—OXTR—GPCRs, Class A Rhodopsin-like—ADRB2—prostate cancer	0.00387	0.00464	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—PLXNB1—prostate cancer	0.00387	0.00463	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—CXCL12—prostate cancer	0.00386	0.00463	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—GRPR—prostate cancer	0.00372	0.00446	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—PTHLH—prostate cancer	0.00342	0.0041	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—MC2R—prostate cancer	0.00337	0.00403	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—ADRB2—prostate cancer	0.00331	0.00397	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—OR51E2—prostate cancer	0.0033	0.00395	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—ANXA1—prostate cancer	0.00322	0.00385	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—WNT4—prostate cancer	0.0032	0.00384	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—NOS3—prostate cancer	0.00317	0.00379	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—MC2R—prostate cancer	0.00306	0.00366	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—BMPR1B—prostate cancer	0.00301	0.00361	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—CALCA—prostate cancer	0.00301	0.00361	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—PENK—prostate cancer	0.003	0.0036	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—CXCL12—prostate cancer	0.00294	0.00353	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—RGS17—prostate cancer	0.0028	0.00336	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—PENK—prostate cancer	0.00272	0.00326	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—prostate cancer	0.0026	0.00311	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—GNRH1—prostate cancer	0.00255	0.00306	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—VIP—prostate cancer	0.00255	0.00306	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—ADRB2—prostate cancer	0.00252	0.00302	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—RLN2—prostate cancer	0.0025	0.00299	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—LPAR1—prostate cancer	0.00247	0.00296	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—GRP—prostate cancer	0.00247	0.00296	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—PLCB2—prostate cancer	0.00245	0.00293	CbGpPWpGaD
Carbetocin—OXTR—Peptide ligand-binding receptors—CXCL8—prostate cancer	0.00239	0.00286	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—HSD17B1—prostate cancer	0.00238	0.00286	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CTBP2—prostate cancer	0.00238	0.00286	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—prostate cancer	0.00237	0.00284	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—PDE4D—prostate cancer	0.00233	0.0028	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—VIP—prostate cancer	0.00232	0.00278	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—GNRH1—prostate cancer	0.00232	0.00278	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PLXNB1—prostate cancer	0.00228	0.00274	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—GRP—prostate cancer	0.00224	0.00269	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—LPAR1—prostate cancer	0.00224	0.00269	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—PLCB2—prostate cancer	0.00222	0.00266	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—GNG5—prostate cancer	0.00222	0.00266	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—GRPR—prostate cancer	0.0022	0.00264	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CX3CL1—prostate cancer	0.00218	0.00261	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—IL17RD—prostate cancer	0.00212	0.00254	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—PDE4D—prostate cancer	0.00212	0.00254	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—GNG5—prostate cancer	0.00202	0.00242	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—PTHLH—prostate cancer	0.00193	0.00232	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—WNT4—prostate cancer	0.00189	0.00227	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—JUP—prostate cancer	0.00189	0.00227	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—ANXA1—prostate cancer	0.00182	0.00218	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—MC2R—prostate cancer	0.00181	0.00216	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—RALBP1—prostate cancer	0.00181	0.00216	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—PTHLH—prostate cancer	0.00176	0.0021	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—PRKACB—prostate cancer	0.00172	0.00206	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—CALCA—prostate cancer	0.0017	0.00204	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—PPP3CA—prostate cancer	0.00168	0.00201	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—CXCL12—prostate cancer	0.00166	0.00199	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—ANXA1—prostate cancer	0.00165	0.00198	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PENK—prostate cancer	0.00161	0.00193	CbGpPWpGaD
Carbetocin—OXTR—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.0016	0.00192	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	0.00158	0.00189	CbGpPWpGaD
Carbetocin—OXTR—Myometrial Relaxation and Contraction Pathways—IL6—prostate cancer	0.00158	0.00189	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CALCA—prostate cancer	0.00155	0.00185	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—GHR—prostate cancer	0.00154	0.00184	CbGpPWpGaD
Carbetocin—OXTR—G alpha (q) signalling events—PIK3CA—prostate cancer	0.00153	0.00184	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—PRKCQ—prostate cancer	0.00152	0.00182	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CXCL12—prostate cancer	0.00151	0.00181	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	0.00149	0.00179	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—NRP1—prostate cancer	0.00147	0.00176	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—ADRB2—prostate cancer	0.00143	0.00171	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—VAV3—prostate cancer	0.00139	0.00167	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—PRKCQ—prostate cancer	0.00138	0.00165	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	0.00137	0.00164	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—VIP—prostate cancer	0.00137	0.00164	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—GNRH1—prostate cancer	0.00137	0.00164	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—ITPR1—prostate cancer	0.00135	0.00162	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—LPAR1—prostate cancer	0.00133	0.00159	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—GRP—prostate cancer	0.00133	0.00159	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—LRP2—prostate cancer	0.00131	0.00157	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PLCB2—prostate cancer	0.00131	0.00157	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—ADRB2—prostate cancer	0.0013	0.00155	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—P4HB—prostate cancer	0.00129	0.00154	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CX3CL1—prostate cancer	0.00129	0.00154	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—VAV3—prostate cancer	0.00126	0.00151	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—HIST1H2BG—prostate cancer	0.00126	0.00151	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—GRB7—prostate cancer	0.00125	0.0015	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PDE4D—prostate cancer	0.00125	0.0015	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—ITPR1—prostate cancer	0.00123	0.00147	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—HIST1H4H—prostate cancer	0.00122	0.00146	CbGpPWpGaD
Carbetocin—OXTR—GPCR ligand binding—CXCL8—prostate cancer	0.00122	0.00146	CbGpPWpGaD
Carbetocin—OXTR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.00121	0.00146	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—GNG5—prostate cancer	0.00119	0.00143	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PTHLH—prostate cancer	0.00104	0.00124	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—TGFBR1—prostate cancer	0.00104	0.00124	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—AKR1C3—prostate cancer	0.00102	0.00122	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PRKACB—prostate cancer	0.00102	0.00122	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—THBS1—prostate cancer	0.00099	0.00119	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PPP3CA—prostate cancer	0.00099	0.00119	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—ANXA1—prostate cancer	0.000975	0.00117	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PRKCZ—prostate cancer	0.000957	0.00115	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—PIK3CG—prostate cancer	0.000936	0.00112	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—FGFR4—prostate cancer	0.000925	0.00111	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PARP1—prostate cancer	0.000925	0.00111	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CALCA—prostate cancer	0.000913	0.00109	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CXCL12—prostate cancer	0.000892	0.00107	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—PIK3CG—prostate cancer	0.00085	0.00102	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CASP9—prostate cancer	0.00084	0.00101	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—PIK3CD—prostate cancer	0.000823	0.000986	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PRKCQ—prostate cancer	0.000814	0.000975	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—NGFR—prostate cancer	0.000814	0.000975	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—MAP3K7—prostate cancer	0.000804	0.000964	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—FGF10—prostate cancer	0.000773	0.000927	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—ADRB2—prostate cancer	0.000765	0.000917	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—JAK2—prostate cancer	0.000755	0.000905	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—MAP2K1—prostate cancer	0.000752	0.000901	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—PIK3CD—prostate cancer	0.000747	0.000895	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—VAV3—prostate cancer	0.000746	0.000894	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—TGFBR2—prostate cancer	0.000736	0.000881	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—ITPR1—prostate cancer	0.000724	0.000867	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—PIK3CB—prostate cancer	0.000717	0.000859	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—IGF1R—prostate cancer	0.000692	0.000829	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—CXCL8—prostate cancer	0.000689	0.000826	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—JAK2—prostate cancer	0.000686	0.000821	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—LPL—prostate cancer	0.000664	0.000795	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—IL2—prostate cancer	0.000658	0.000789	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PDGFRB—prostate cancer	0.000658	0.000788	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—PIK3CB—prostate cancer	0.000651	0.00078	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—ITGB3—prostate cancer	0.000641	0.000768	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—CXCL8—prostate cancer	0.000626	0.00075	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—ERBB3—prostate cancer	0.000622	0.000745	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—FGFR2—prostate cancer	0.000621	0.000744	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—IL2—prostate cancer	0.000598	0.000716	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—TERT—prostate cancer	0.000596	0.000714	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—HIF1A—prostate cancer	0.00057	0.000683	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—LEP—prostate cancer	0.000556	0.000666	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CAV1—prostate cancer	0.000551	0.00066	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—KDR—prostate cancer	0.000545	0.000653	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—ESR1—prostate cancer	0.000531	0.000636	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—BAD—prostate cancer	0.000518	0.000621	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—APC—prostate cancer	0.000502	0.000601	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PIK3CG—prostate cancer	0.000502	0.000601	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—EGF—prostate cancer	0.000496	0.000594	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—IRS1—prostate cancer	0.000496	0.000594	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—GSK3B—prostate cancer	0.000482	0.000577	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—INS—prostate cancer	0.000475	0.000569	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CREBBP—prostate cancer	0.000465	0.000558	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—IGF1—prostate cancer	0.00046	0.000551	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—EGFR—prostate cancer	0.000457	0.000548	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—MAP2K1—prostate cancer	0.000444	0.000532	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PIK3CD—prostate cancer	0.000441	0.000529	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—PIK3CA—prostate cancer	0.000437	0.000524	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—SERPINE1—prostate cancer	0.000436	0.000523	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—KRAS—prostate cancer	0.000432	0.000518	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—FGF2—prostate cancer	0.000422	0.000506	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—NOS3—prostate cancer	0.000417	0.000499	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—JAK2—prostate cancer	0.000405	0.000485	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—PIK3CA—prostate cancer	0.000397	0.000476	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—MDM2—prostate cancer	0.000395	0.000474	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—ERBB2—prostate cancer	0.00039	0.000467	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PIK3CB—prostate cancer	0.000385	0.000461	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CXCL8—prostate cancer	0.00037	0.000443	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CDKN1B—prostate cancer	0.000361	0.000432	CbGpPWpGaD
Carbetocin—OXTR—GPCR downstream signaling—AKT1—prostate cancer	0.000357	0.000428	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CASP3—prostate cancer	0.000354	0.000424	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—IL2—prostate cancer	0.000353	0.000423	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—IL6—prostate cancer	0.000351	0.000421	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CCND1—prostate cancer	0.000344	0.000413	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CTNNB1—prostate cancer	0.000341	0.000409	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—MMP9—prostate cancer	0.000334	0.000401	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—CDKN1A—prostate cancer	0.000333	0.000399	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PTEN—prostate cancer	0.000332	0.000398	CbGpPWpGaD
Carbetocin—OXTR—Signaling by GPCR—AKT1—prostate cancer	0.000324	0.000388	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—EP300—prostate cancer	0.000317	0.00038	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—SRC—prostate cancer	0.000308	0.000369	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—VEGFA—prostate cancer	0.0003	0.00036	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—STAT3—prostate cancer	0.000297	0.000356	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—MYC—prostate cancer	0.000276	0.000331	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—TGFB1—prostate cancer	0.000276	0.00033	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—EGFR—prostate cancer	0.00027	0.000324	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—KRAS—prostate cancer	0.000255	0.000306	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—PIK3CA—prostate cancer	0.000234	0.000281	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—TP53—prostate cancer	0.000227	0.000272	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—IL6—prostate cancer	0.000208	0.000249	CbGpPWpGaD
Carbetocin—OXTR—Signaling Pathways—AKT1—prostate cancer	0.000192	0.000229	CbGpPWpGaD
